BOSTON SCIENTIFIC CORP
corporate_fare Company Profile
BOSTON SCIENTIFIC CORP (NYSE:BSX) is a publicly traded company in the Life Sciences sector. Wiseek monitors BSX SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.
Recent high-impact activity:
- Boston Scientific to Acquire Penumbra in Multi-Billion Dollar Cash and Stock Deal
- Boston Scientific to Acquire Penumbra for $14.5 Billion, Expanding Cardiovascular and Neurovascular Portfolio
Financial Snapshot
Fiscal year ended December 31, 2025
Revenue
$20.07B
Net Income
$2.89B
Diluted EPS
$1.94
Op. Cash Flow
$4.53B
Free Cash Flow
$3.66B
Gross Profit
$13.85B
Operating Income
$3.61B
Cash & Equivalents
$1.97B
Total Debt
$299M
Debt / Equity
0.01×
Net Margin
14.4%
Shares Outstanding
1.48B sh
Source: 10-K · filed 2026-02-17 · accession 0000885725-26-000010
Recent Capital Actions
-
2026-02-27 Proposed Mixed Merger +43.85M sh
-
2026-02-26 Executed Long-term debt ↓ −$3.27B (net of 7 line items)
-
2026-02-26 Executed Total debt ↓ −$3.27B (net of 7 line items)
Detected from SEC filings (8-K, S-4, POS AM, 6-K). Last 12 months.
show_chartPrice Chart
Loading chart...